INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 158 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,833,563 | -29.9% | 89,613 | -9.5% | 0.00% | -33.3% |
| Q2 2023 | $4,039,422 | +16.5% | 99,054 | +6.4% | 0.01% | +20.0% |
| Q1 2023 | $3,468,123 | +6.4% | 93,054 | -0.4% | 0.01% | 0.0% |
| Q4 2022 | $3,260,645 | -34.2% | 93,455 | +5.6% | 0.01% | -37.5% |
| Q3 2022 | $4,954,000 | +7.1% | 88,522 | -0.9% | 0.01% | +14.3% |
| Q2 2022 | $4,625,000 | -26.8% | 89,360 | +2.7% | 0.01% | -12.5% |
| Q1 2022 | $6,320,000 | -43.1% | 86,973 | -7.4% | 0.01% | -38.5% |
| Q4 2021 | $11,108,000 | -5.3% | 93,941 | +7.4% | 0.01% | -13.3% |
| Q3 2021 | $11,730,000 | -17.7% | 87,436 | -0.7% | 0.02% | -16.7% |
| Q2 2021 | $14,255,000 | +114.7% | 88,044 | +6.4% | 0.02% | +100.0% |
| Q1 2021 | $6,641,000 | +61.0% | 82,746 | +9.1% | 0.01% | +50.0% |
| Q4 2020 | $4,125,000 | +173.5% | 75,834 | 0.0% | 0.01% | +200.0% |
| Q3 2020 | $1,508,000 | +8.6% | 75,834 | +14.8% | 0.00% | 0.0% |
| Q2 2020 | $1,389,000 | +94.5% | 66,085 | +13.2% | 0.00% | 0.0% |
| Q1 2020 | $714,000 | -19.2% | 58,392 | -3.1% | 0.00% | 0.0% |
| Q4 2019 | $884,000 | +10.0% | 60,244 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $804,000 | -12.4% | 60,244 | +7.5% | 0.00% | 0.0% |
| Q2 2019 | $918,000 | +5.6% | 56,051 | +10.2% | 0.00% | 0.0% |
| Q1 2019 | $869,000 | +22.4% | 50,871 | -2.2% | 0.00% | 0.0% |
| Q4 2018 | $710,000 | -51.2% | 52,038 | +2.4% | 0.00% | -33.3% |
| Q3 2018 | $1,455,000 | +4.6% | 50,829 | -0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,391,000 | +161.0% | 50,847 | +101.2% | 0.00% | +200.0% |
| Q1 2018 | $533,000 | +5.5% | 25,270 | -3.8% | 0.00% | 0.0% |
| Q4 2017 | $505,000 | -12.9% | 26,272 | +12.5% | 0.00% | 0.0% |
| Q3 2017 | $580,000 | +44.3% | 23,343 | -7.2% | 0.00% | 0.0% |
| Q2 2017 | $402,000 | +103.0% | 25,143 | +79.0% | 0.00% | – |
| Q1 2017 | $198,000 | +5.3% | 14,043 | -2.1% | 0.00% | – |
| Q4 2016 | $188,000 | -25.1% | 14,343 | -2.7% | 0.00% | -100.0% |
| Q3 2016 | $251,000 | -19.8% | 14,743 | +0.7% | 0.00% | 0.0% |
| Q2 2016 | $313,000 | – | 14,643 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |